Analytical Performance Evaluation of a 523-Gene Circulating Tumor DNA Assay for Next-Generation Sequencing–Based Comprehensive Tumor Profiling in Liquid Biopsy Samples
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analytical Performance Evaluation of a 523-Gene Circulating Tumor DNA Assay for Next-Generation Sequencing–Based Comprehensive Tumor Profiling in Liquid Biopsy Samples
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR DIAGNOSTICS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-20
DOI
10.1016/j.jmoldx.2023.10.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study
- (2023) A. Bayle et al. ANNALS OF ONCOLOGY
- Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA
- (2022) Jonathan Poh et al. PLoS One
- ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
- (2022) J. Pascual et al. ANNALS OF ONCOLOGY
- Liquid biopsy enters the clinic — implementation issues and future challenges
- (2021) Michail Ignatiadis et al. Nature Reviews Clinical Oncology
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
- (2021) Ira W. Deveson et al. NATURE BIOTECHNOLOGY
- Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA
- (2021) Justin D. Finkle et al. npj Precision Oncology
- PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers
- (2021) E.E. Dumbrava et al. ESMO Open
- Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
- (2020) Marco Russano et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
- (2020) Ryan Woodhouse et al. PLoS One
- Mutational Landscape and Evolutionary Pattern of Liver and Brain Metastasis in Lung Adenocarcinoma
- (2020) Tao Jiang et al. Journal of Thoracic Oncology
- Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
- (2019) Dominic G. Rothwell et al. NATURE MEDICINE
- Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study
- (2019) Andrea Forschner et al. Journal for ImmunoTherapy of Cancer
- CNV Detection from Circulating Tumor DNA in Late Stage Non-Small Cell Lung Cancer Patients
- (2019) Hao Peng et al. Genes
- Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies
- (2018) Justin I. Odegaard et al. CLINICAL CANCER RESEARCH
- Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA
- (2018) Travis A. Clark et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases
- (2018) J Seoane et al. ANNALS OF ONCOLOGY
- Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer
- (2018) Charu Aggarwal et al. JAMA Oncology
- Complication rates of CT-guided transthoracic lung biopsy: meta-analysis
- (2016) W. J. Heerink et al. EUROPEAN RADIOLOGY
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
- (2016) Jeanne Tie et al. Science Translational Medicine
- Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology
- (2015) Andreas Heindl et al. LABORATORY INVESTIGATION
- EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291
- (2015) Kenneth S. Thress et al. LUNG CANCER
- Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
- (2014) Jean-Yves Douillard et al. Journal of Thoracic Oncology
- Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
- (2014) E. C. de Bruin et al. SCIENCE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive Histologic Assessment Helps to Differentiate Multiple Lung Primary Nonsmall Cell Carcinomas From Metastases
- (2009) Nicolas Girard et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started